Evidence map›Paper›PMID 22078927›Full record

ReviewColloids and surfaces. B, Biointerfaces2012

Cancer nanomedicines targeting tumor extracellular pH.

Li Tian, You Han Bae

Abstract readReview
In one paragraph

Review in Colloids and surfaces. B, Biointerfaces, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Theranostic Fluorescent Probes.Chemical reviews · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Engineering Targeting Materials for Therapeutic Cancer Vaccines.Frontiers in bioengineering and biotechnology · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Tumor Microenvironment Targeted Nanotherapy.Frontiers in pharmacology · 2018
    Article
  18. Article
  19. Article
  20. pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Li TianDepartment of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84108, USA.
You Han Bae

Funding

Micelle surface engineering for active targeting by acidic tumor extracellular pHR01CA122356 · NCI · UNIVERSITY OF UTAH · PI BAE, YOU HAN · 2006 to 2010
$1.3M
NCI NIH HHS CA 122356NCI NIH HHS R01 CA122356
6 · The paper itself

Abstract

Tumors have been a highlight in the research of nanomedicine for decades. Despite all the efforts in the decoration of the nano systems, tumor specific targeting is still an issue due to the heterogeneous nature of tumors. Hypoxia is frequently observed in solid tumors. The consequent acidification of tumor extracellular matrices may bring new insight to tumor targeting. In this review, we present the polymeric nano systems that target tumor extracellular pH (pH(e)).

Indexed as

ProtonsAntineoplastic AgentsDrug Delivery SystemsHumansHydrogen-Ion ConcentrationHypoxiaMagnetic Resonance SpectroscopyMicroelectrodesMolecular Targeted TherapyNanomedicineNanoparticlesNeoplasmsPolymersSulfonamidesTumor MicroenvironmentAntineoplastic AgentsPolymersProtonsSulfonamides

Identifiers

PMID22078927
PMCPMC3345308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.